These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Surfactant of the lung. Heinemann HO. Adv Intern Med; 1968; 14():83-105. PubMed ID: 4883747 [No Abstract] [Full Text] [Related]
28. [Pulmonary surfactan. Current physiological and physiopathological concepts]. Pariente R. Presse Med (1893); 1969 Nov 26; 77(50):1871-2. PubMed ID: 5197179 [No Abstract] [Full Text] [Related]
29. Reliability of continuous transcutaneous PO2 (Hellige) in respiratory distress syndrome of the newborn. Duc G, Frei H, Klar H, Tuchschmid P. Birth Defects Orig Artic Ser; 1979 Nov 26; 15(4):305-13. PubMed ID: 534710 [No Abstract] [Full Text] [Related]
30. [Surface tension within the lung and hyaline membrane disease]. Benzer H, Lempert J, Regele H. Wien Klin Wochenschr; 1969 Feb 28; 81(9):145-9. PubMed ID: 5784059 [No Abstract] [Full Text] [Related]
31. [The surface-active substance of the lung (antiatelectasis factor), a literature review]. Renovanz HD, Krishnabhakdi C. Dtsch Med J; 1969 Mar 28; 20(6):194-200. PubMed ID: 4892894 [No Abstract] [Full Text] [Related]
34. THE COURSE OF THE RESPIRATORY DISTRESS SYNDROME OF NEWBORN INFANTS. AS INDICATED BY POOR STABILITY OF PULMONARY EXPANSION. GRUENWALD P. Acta Paediatr (Stockh); 1964 Sep 28; 53():470-7. PubMed ID: 14215780 [No Abstract] [Full Text] [Related]
35. The role of esophageal dysfunction in the pulmonary effects of experimental vagotomy. Milley PS. Am J Pathol; 1968 Apr 28; 52(4):917-33. PubMed ID: 5184528 [No Abstract] [Full Text] [Related]